Beximco Pharmaceuticals Ltd. GDR Stock
The Beximco Pharmaceuticals Ltd. GDR price is unchanged compared to yesterday.
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 0.980% | 0.000% | 18.119% | 14.955% | 4.251% | -47.179% |
| Eledon Pharmaceuticals Inc. | -2.720% | 11.515% | 0.546% | -54.455% | 43.750% | -24.590% | -87.815% |
| SELLAS Life Sciences Group Inc | 9.660% | 16.556% | -8.453% | 190.909% | 24.162% | -2.709% | -50.865% |
| Grifols S.A. ADR | -0.640% | 3.974% | 3.974% | 12.950% | 3.289% | -9.249% | -40.186% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%